2021
DOI: 10.1007/s10147-021-01925-9
|View full text |Cite
|
Sign up to set email alerts
|

Long-term results of fluorescence and indigo carmine blue dye-navigated sentinel lymph node biopsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…Indigo carmine blue has also been used as a dye for sentinel lymph node biopsy during breast cancer surgery. The safety of indigo carmine blue injection has also been confirmed ( 7 – 10 ). The aim of our study was to evaluate our strategy in the pre-operative localization of ectopic parathyroid adenomas (EPAs), emphasizing the contribution of a dye method (i.e., indigo carmine blue injection) and an intraoperativeb PTH assay.…”
Section: Introductionmentioning
confidence: 84%
“…Indigo carmine blue has also been used as a dye for sentinel lymph node biopsy during breast cancer surgery. The safety of indigo carmine blue injection has also been confirmed ( 7 – 10 ). The aim of our study was to evaluate our strategy in the pre-operative localization of ectopic parathyroid adenomas (EPAs), emphasizing the contribution of a dye method (i.e., indigo carmine blue injection) and an intraoperativeb PTH assay.…”
Section: Introductionmentioning
confidence: 84%
“…To study this possible mechanism, we hope to publish a graph of disease-free survival and overall survival from the 60-month follow-up of patients participating in this research soon. Asaga et al published in 2021 a study with 565 patients with an even longer follow-up of 83 months, demonstrating results with a favorable prognosis (disease-free survival of 92.4% and overall survival of 97.3% and reiterating that the ICG technique is an alternative to the use of technetium in patients with breast cancer with clinically negative armpits [ 32 ]. Wang et al [ 33 ] published, also in 2021, a study with an even larger number of patients evaluated (969) and a mean follow-up of 5.6 years (2–9.3 years) reporting only 0.64% of axillary recurrence.…”
Section: Discussionmentioning
confidence: 99%